Disclosure Of First-Time Adoption [Text Block]

Transgene - Filing #858281

Concept	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	As at 2022-12-31	As at 2022-12-31	2022-01-01 to 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	As at 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31
Disclosure of first-time adoption [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of comparative information prepared under previous GAAP [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of comparative information prepared under previous GAAP [abstract]
Disclosure of comparative information prepared under previous GAAP [line items]
Equity	—	—	—	50 628 EUR	32 804 EUR	—	808,000 EUR	450,000 EUR	70 813 EUR	50 102 EUR	37 841 EUR	—	—	—	—	19 536 EUR	2 933 EUR	—	—	—	31 092 EUR	—	—	—	1 423 EUR	67 209 EUR	67 441 EUR	—	48 886 EUR	—	50 716 EUR	41 921 EUR	1 051 EUR	17 231 EUR	13 861 EUR	39 212 EUR	1 726 EUR
Comprehensive income	- EUR	- EUR	31 831 EUR	—	—	- EUR	—	—	—	—	—	973,000 EUR	32 804 EUR	31 831 EUR	- EUR	—	—	- EUR	19 908 EUR	372,000 EUR	—	- EUR	- EUR	19 536 EUR	—	—	—	- EUR	—	19 908 EUR	—	—	—	—	—	—	—
Profit (loss)	- EUR	- EUR	32 804 EUR	—	—	- EUR	—	—	—	—	—	- EUR	32 804 EUR	32 804 EUR	- EUR	—	—	- EUR	19 536 EUR	- EUR	—	- EUR	- EUR	19 536 EUR	—	—	—	- EUR	—	19 536 EUR	—	—	—	—	—	—	—